Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

MTS may buy Mars Media Entertainment production center

12/25/23 MTSS

Henderson's LFL sales grew 27.3% in the January-November period

12/25/23 HNFG

Foreign shareholders of Arctic LNG-2 declared force majeure

12/25/23 NVTK

Tatneft shareholders failed to approve dividends

12/25/23 TATN

Rosbank will buy a portfolio of Russian public companies from Societe Generale

12/25/23 ROSB

U.S. bans imports of products from fish caught in Russia

12/22/23 AQUA

Sberbank issues DFA on the digital square meter index

12/22/23 SBER

SberMarket has connected the SimpleWine network of wine shops

12/22/23 SBER

VK has withdrawn from the capital of the marketplace for business Develop RF

12/22/23 VKCO

VTB targets ₽646 billion net profit in 2026

12/22/23 VTBR